Health & Medicine Week articles from June 2004

Health & Medicine Week archives from June 2004

Adrenal masses are often discovered incidentally.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Researchers review hundreds of articles and present a comprehensive discussion of the diagnosis and management of adrenal masses. "Clinically inapparent adrenal masses are incidentally detected...

Growing epidemic of wet AMD alarms retina specialists.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Nearly all retina specialists are greatly alarmed by the increasing number of cases of wet age-related macular degeneration (AMD), the leading cause of severe vision loss and blindness in people over...

Age-dependent antidepressant pharmacogenomics reported.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Polymorphisms of the serotonin transporter and G protein beta 3 subunit can predict the response to fluoxetine and nortriptyline. "In 169 depressed patients randomized to treatment with either...

Pretreatment with hydroxyurea lowers rejection incidence in sickle cell disease.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Pretreatment with hydroxyurea lowers the rejection incidence in sickle cell disease. According to scientists in Belgium, "Since 1988, 24 children have undergone hematopoietic stem cell...

Pathogenesis and therapeutic options for West Nile virus reviewed.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Researchers review the pathogenesis of and therapeutic options for West Nile virus in a recent issue of the Annals of Internal Medicine According to a study from the United States, "West Nile virus,...

Scientists discover how AIDS opens cell doors.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Researchers at the Salk Institute have discovered a way to view viruses like HIV upon cell entry. Published in the May 18 edition of the Proceedings of the National Academy of Sciences, this...

Small study shows weekly cycles of anti-HIV drugs successful.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- A small study conducted at the U.S. National Institutes of Health (NIH) showed that treatment of HIV-infected patients with a once-daily regimen of anti-HIV drugs given in pre-planned, 7-day-on,...

Antibody light chain cleaves chemokine receptor CCR-5 peptide.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Researchers report the discovery of a catalytic antibody light chain capable of cleaving a chemokine receptor CCR-5 peptide with a high reaction rate constant. "A monoclonal antibody (MAb), ECL2B-2,...

Nucleoside analogues and mitochondrial toxicity reviewed.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Scientists review nucleoside analogues and mitochondrial toxicity in a recent issue of Clinical Infectious Diseases. "An evaluation of the U.S. Food and Drug Administration's Adverse Event...

HIV replication reduced in cells with zinc finger transcription factor.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Primary human cells with a designed zinc finger transcription factor show attenuated HIV-1 replication. "Small molecule inhibitors of human immunodeficiency virus, type 1 (HIV-1) have been...

Cardinal Health buys intravenous medical supply company.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- The drug wholesaler and distributor Cardinal Health Inc. said that it has agreed to pay $1.6 billion for Alaris Medical Systems Inc., a San Diego-based maker of intravenous medication products and...

Valley Baptist buys Brownsville Medical Center.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Valley Baptist Health System is buying Brownsville Medical Center from Tenet Healthcare Corp. for an undisclosed price, Valley Baptist officials said May 17, 2004. Tenet, the nation's second-largest...

Company announces reinitiation of phase IIa trial in ACS.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Nuvelo, Inc., (NUVO) announced reinitiation and enrollment of the first patient in a phase IIa trial with recombinant nematode anticoagulant protein c2 (rNAPc2), for the treatment of patients with acute...

Ceplene trial in AML meets primary trial endpoint.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Maxim Pharmaceuticals (MAXM) announced the results of an international phase III clinical trial testing the combination of Ceplene plus interleukin-2 (IL-2) in 320 patients with acute myeloid leukemia...

Health workers in Uganda need training to help teens with sexual health issues.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- For young people in northern Uganda, health workers are an important source of sexual and reproductive health information. But a study finds health workers in the region need more training and...

Working teens increasingly victims of sexual harassment.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Sociologists say sexual harassment of working teens is grossly under-reported and misunderstood. This type of aggression, they say, has lasting impact as adolescents become adults in the workforce....

Nationwide recall made of instructions for use of biliary stent.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Cordis Endovascular, a division of Cordis Corporation, a Johnson & Johnson company, is recalling revised instructions for use for the Precise RX Nitinol Stent Transhepatic Biliary System, contained in...

Consumers misinformed, but still use anti-aging products, procedures.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- According to new data released by the National Consumers League (NCL), Americans are interested but misinformed about options to reduce the visible signs of aging. The online survey of 1343 adults...

New survey reveals dramatic rise in "aging face" surgical procedures.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Baby boomers do not seem to be content to grow old gracefully according to a new survey by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). Rhytidectomy surgeries...

Visudyne launched in Japan for treatment of age-related macular degeneration.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Novartis Pharma AG announced that Visudyne (verteporfin) treatment for some forms of "wet" Age-Related Macular Degeneration (AMD) was launched in Japan. Visudyne was approved by the Japanese...

Cancer checks at 80: When is it too old to test?
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Does an 80-year-old really need a Pap smear? Do mammograms in the 70s find dangerous breast cancer or tumors that are too slow-growing to threaten women's last years? The question of when you're...

Scientists link fruit fly gene to aging.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Scientists from the Weill Cornell Medical College have identified a fruit fly gene linked to aging, according to a study published in the May 9 online issue of Nature Cell Biology. Researchers...

Girls living with alcoholic stepfather have more behavior problems than boys.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Living with an alcoholic stepfather is associated with a significantly higher risk of behavior problems in girls than boys, according to a new study by researchers at Virginia Commonwealth University...

Diagnosis and treatment of allergy to hymenoptera wasp stings reviewed.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- The diagnosis and treatment of hymenoptera wasp stings in allergic patients has been reviewed. According to recent research from Switzerland, there is "considerable potential to improve both...

Expression of c-FLIPL promotes Th2 allergic airway reactions in mice.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Cellular FLIP long form (c-FLIPL)-transgenic mice show greater susceptibility to Th2-induced allergic airway inflammation. According to immunologists in the United States, c-FLIPL is "a...

ABAD links A beta to mitochondrial toxicity in Alzheimer disease.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- A-beta-binding alcohol dehydrogenase (ABAD) directly links A-beta to mitochondrial toxicity in Alzheimer disease. "Mitochondrial dysfunction is a hallmark of beta-amyloid (A-beta)-induced neuronal...

Data released on review of Amyloid clinical trial.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Axonyx, Inc., (AXYX) announced that the blinded data review that statistically reassessed the original variability estimate of the available data from the ongoing phase IIB Amyloid beta (A(B)) trial...

License extended for sale of monoclonal antibodies.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Senetek PLC (SNTK) announced an extension of its agreement with the research foundation under which Senetek is licensed to manufacture and sell monoclonal antibodies used to research various disease...

Melatonin supplementation reduces amyloid beta-peptide levels.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Dietary supplementation with melatonin reduces levels of amyloid beta-peptides in the murine cerebral cortex. According to recent research from the United States, "Melatonin levels decrease with...

Neprilysin has anti-amyloid activity in models of Alzheimer disease.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Neprilysin exhibits anti-amyloid activity in plaque-bearing mouse models of Alzheimer disease. According to recent research published in the journal FEBS Letters, "Abnormally high concentrations of...

Protein found to dissolve amyloid fibers.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Research published in the May 21 online issue of Science shows a natural biological process by which yeast protein cells dismantle amyloid fibers, protein plaques found in the brains of patients with...

Cdk5 is therapeutic target for Alzheimer disease.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Cdk5 may be a therapeutic target for Alzheimer disease. According to recent research from the United States, "Alzheimer disease (AD) represents the leading cause for senile dementia affecting more...

Molecular signature of ALS found in profile of spinal cord gray matter.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- The molecular signature of late-stage human amyotropic lateral sclerosis (ALS) has been revealed by expression profiling of postmortem spinal cord gray matter. "Little is known about global gene...

Pharmacological management of amyotropic lateral sclerosis reviewed.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Researchers review current pharmacological management strategies of amyotrophic lateral sclerosis and a role for rational polypharmacy in a recent issue of Expert Opinion on Pharmacotherapy. ...

Benign and malignant disorders can be similar to perianal dermatitis.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Biopsy should be performed if anal dermatitis is unresponsive to therapy, researchers say. According to recent research published in the journal Hautarzt, "Perianal dermatitis is one of the most...

FDA approves LidoSite Topical System for local analgesia.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Vyteris, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Vyteris' New Drug Application (NDA) for its LidoSite Topical System. The system has been approved for use on...

Researchers identify compound in embryonic development that inhibits new blood vessel growth.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Researchers at the Weill Cornell Medical College have identified compounds in embryos that inhibit the growth of new blood vessels. Results of the animal studies have been published in the May 11 issue...

Ablation of SM22 alpha decreases contractility of vascular muscle.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Ablation of SM22 alpha decreases contractility and actin contents of mouse vascular smooth muscle. According to recent research published in the journal FEBS Letters, "The actin-binding protein...

Long-term therapy for chronic hepatitis C resolves hereditary telangiectasia.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Long-term therapy for chronic hepatitis C resolves hereditary telangiectasia. According to recent research from the United States, "hereditary hemorrhagic telangiectasia is a group of autosomal...

Platelet factor-4 and its derivatives control angiogenesis and invasion.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Platelet factor-4 and its derivatives control angiogenesis and invasion. "Platelet factor-4 (PF-4) is a glutamic acid-leucine-arginine (ELR)-negative chemokine that exhibits antiangiogenesis...

Role of receptors on pulmonary artery contraction outlined.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Scientists outline the role of alpha-adrenergic receptors in the effect of the beta-adrenergic receptor ligands, CGP 12177, bupranolol, and SR 59230A, on the contraction of rat intrapulmonary arteries....

Anthim selected for testing by U.S. federal government.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Elusys Therapeutics, Inc., announced that its anti-anthrax antibody, trade name Anthim(ETI-204), was selected by the U.S. Centers for Disease Control and Prevention (CDC) for evaluation by the...

Conjugate induces antibodies to capsule of B. anthracis.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Immunization with a synthetic peptide-carrier protein conjugate induces opsonic antibodies to the gamma-D-glutamic acid capsule of Bacillus anthracis. "The capsule of Bacillus anthracis, a polymer...

Cyanovirin-N antiviral activity evaluated.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Scientists evaluated cyanovirin-N antiviral activity using lentiviral vectors pseudotyped with filovirus envelope glycoproteins. According to published research from the United States and Spain,...

Encouraging antibiotic portfolio discussed at European meeting.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Bayer Pharmaceuticals Corporation continues to demonstrate its dedication to research and development in the anti-infective arena as evidenced by encouraging data presented at this year's European...

New compounds antifungal and anticancer but inactive against HIV-1 and bacteria.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- New alpha-(N)-heterocyclichydrazones have antifungal and anticancer properties but are inactive against HIV-1 and bacteria. According to recent research from Italy, "A series of 3- and...

Serine protease from Bombyx mori larvae exhibits antiviral activity.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- A serine protease from the digestive juice of Bombyx mori larvae exhibits antiviral activity against nucleopolyhedrovirus. According to recent research from Japan, "A protein showing strong...

Gastrins play direct or indirect role in anxiety-like behavior.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Gastrins play a direct or indirect role in regulating locomotor activity and anxiety-like behavior. "The current studies were initiated to investigate the role of brain-gut peptide, gastrin, on...

Cisplatin-induced apoptosis associated with mitochondrial dysregulation.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Cisplatin-induced apoptosis is associated with mitochondrial dysregulation. "Human hepatoma cell lines undergo apoptosis after treatment with cisplatin (CP), by mechanisms that are not fully...

Cyclic AMP activation of ERK1/2 leads to transient inhibition of apoptosis.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Cyclic AMP activation of ERK1/2 leads to transient inhibition of apoptosis. "The proliferative compartment of the intestinal crypt is critical in the process of intestinal epithelial cell...

DRG2 overexpression reduces sensitivity to nocodazole-induced apoptosis.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Overexpression of DRG2 increases G[subscript]2/M phase cells and decreases sensitivity to nocodazole-induced apoptosis. According to published research from South Korea, "DRG2, a member of the DRG...

Nerve growth factor attenuates endoplasmic reticulum apoptosis.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Nerve growth factor attenuates endoplasmic reticulum stress-mediated apoptosis via suppression of caspase-12 activity. "Following endoplasmic reticulum (ER) stress, which occurs via inhibition of...

Nuclear protein kinase C isoforms and apoptosis reviewed.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Scientists review nuclear protein kinase C isoforms and apoptosis in a recent issue of the European Journal of Histochemistry. According to recent research from Italy, "The process of apoptosis is...

Phosphorylation on Thr-55 by TAN mediates degradation of p53.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Phosphorylation on Thr-55 by TAN mediates degradation of p53, indicating a role for TAN in cell G1 progression. "The largest subunit of TFIID, TAF1, possesses an intrinsic protein kinase activity...

Pro168 exhibits control of Bax localization and apoptotic activity.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Pro168 exhibits conformational control of Bax localization and apoptotic activity. According to a study from Germany, "In healthy cells, Bax resides inactive in the cytosol because its COOH-terminal...

Computer aided detection products manufacturer appoints new board members.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- iCAD, Inc., (ICAD) announced the addition of George Farley, Rachel Brem, MD, and Herschel J. Sklaroff, MD, to its board of directors. Brem's term runs through 2005 and Farley's and Sklaroff's terms...

Device maker submits PMA for vascular closure system.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Angiolink Corporation has submitted its premarket approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its EVS Vascular Closure System. The company expects to receive FDA...

Both complement activation pathways are involved in arthritis pathogenesis.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Both of the complement activation pathways are involved in arthritis pathogenesis. "To analyze the role of the classical and alternative pathways of complement activation in the effector phase of...

Top 10 reasons why arthritis sufferers should exercise.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Arthritis is becoming more and more common - and not just among the very old. The American Council on Exercise (ACE), America's non-profit fitness advocate, suggests 10 reasons for arthritis...

Baby born from sperm frozen for record 21 years.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Researchers in England have reported what they believe to be a world record: a baby born using sperm that had been frozen for 21 years. The announcement came in the May 25, 2004, issue of Human...

Comparison of sperm preparation techniques for IUI favors swim-up method.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- A comparison of the albumin, Percoll, Puresperm, and swim-up methods of preparing semen for intrauterine insemination resulted in the last being the technique of choice for one Taipei hospital's ob/gyn...

Patients who worry about aspects of IVF less likely to conceive.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Researchers at the University of California, San Diego, have found that patients who worry about certain aspects of their assisted reproductive technology (ART) cases are likely to produce fewer eggs...

Several factors influence women's decisions about multifetal reduction.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Several factors influencing women's decisions about multifetal reduction when they've conceived higher-order multiple pregnancies were identified in a recent study. K.S. Collopy and colleagues in...

Anti-inflammatory mechanics of 1,25-dihydroxyvitamin D3 clarified.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- The anti-inflammatory mechanics of 1,25(OH)[subscript]2D[subscript]3 have been elucidated. "The fat soluble vitamin D3 metabolite 1,25-dihydroxyvitamin D3 [1,25(OH)[subscript]2D[subscript]3], and...

Utility of exhaled NO measurement in asthma monitoring reviewed.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- The utility of exhaled NO measurement in asthma monitoring has been reviewed. "Nitric oxide (NO) is present in the upper and lower human airways. Nasal and exhaled levels of NO can be determined by...

Optimal doses of inhaled budesonide determined.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- The optimal doses of inhaled budesonide have been determined. Scientists in New Zealand conducted a study "to examine the dose-response relationship of inhaled budesonide in adolescents and adults...

Atrial fibrillation study commences with Arctic Circler Balloon catheter.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- CryoCath Technologies, Inc., announced that a human feasibility study involving the first 13 patients using the company's proprietary Arctic Circler Balloon catheter to treat atrial fibrillation (AF)...

Lenox Hill Hospital completes less invasive procedures to treat atrial fibrillation.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Marking a major first for Cardima, Inc.'s (CRDM) Surgical Ablation System (SAS), doctors at Lenox Hill Hospital in New York City, New York, reported two successful "less invasive" cases using the system...

Panel recommends continuation of phase III atrial arrhythmia trial.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Cardiome Pharma Corp. ( COM) announced that it's independent Data Safety Monitoring Board (DSMB) has issued a recommendation to continue the phase III clinical trial, ACT 1, evaluating intravenous...

Robert P. Hickey announces drug-delivery development program.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Robert P. Hickey, president and CEO of Life Medical Sciences, Inc., (CHAI) announced that the company has undertaken a development program intended to provide cardiac surgeons with the first-ever...

ADHD patients have more symptom improvement with Concerta vs. Strattera.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Children with attention deficit/hyperactivity disorder (ADHD) demonstrated greater improvement with symptoms such as hyperactivity, impulsivity, and attention with Concerta (methylphenidate HCl) CII...

The Assessment Center introduces DataLex AD/HD report.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- The Assessment Center has introduced a new, objective biological indicator for the assessment of attention deficit/hyperactive disorder (AD/HD) at its four New York Metro locations. The DataLex...

Report finds no evidence links autism to mercury in vaccines.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- There is no evidence that a controversial mercury-based vaccine preservative causes autism, concludes a scientific review that says it's time to lay to rest vaccine suspicions and to find the real...

Maternal chimeric T cells underlies juvenile dermatomyositis.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Maternal chimeric T cells are involved in the pathogenesis of juvenile dermatomyositis (JDM). According to immunologists in Minnesota, JDM "is a multisystem autoimmune disease that at times...

Mycophenolate mofetil prevents autoimmune glomerulonephritis in rats.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Mycophenolate mofetil attenuates autoimmune glomerulonephritis in rats. In a recent study, scientists in Japan investigated "the effects of mycophenolate mofetil, a specific inhibitor of inosine...

Prednisolone inhibits antigen-specific expansion of natural killer cells.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- The steroid prednisolone suppresses antigen-specific expansion of natural killer cells in patients with autoimmune disorders. "The mechanisms of action of most treatments in the autoimmune...

Murine model of type 2 autoimmune hepatitis developed.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Researchers have developed a murine model of type 2 autoimmune hepatitis. "Autoimmune hepatitis (AIH) is characterized by an immune-mediated injury of the hepatic parenchyma of unknown...

Campylobacter jejuni genes involved in GI tract colonization are identified.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Campylobacter jejuni genes that are involved in gastrointestinal tract colonization have been identified. "Campylobacter jejuni is the leading cause of bacterial gastroenteritis in humans in...

CIGNA Behavioral Health announces enhanced web-based services.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- CIGNA Behavioral Health (CBH) has enhanced its online capabilities to encourage consumers to access confidential help, coaching, information, and support via the web. CBH website users have grown...

Sexual dysfunction in BPH patients higher than surveyed physicians estimate.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- The incidence of sexual dysfunction in patients suffering from benign prostatic hyperplasia (BPH) - or enlarged prostate - is nearly twice as high as treating physicians believe, shows a new survey from...

Study patients show greater symptom improvement with Avodart vs. Proscar.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- New data presented at the annual meeting of the American Urological Association suggest that treatment with Avodart, the dual 5 alpha-reductase inhibitor (5ARI), may provide faster onset of symptom...

U.S. Department of Homeland Security awards $7.5M biodefense contract.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- U.S. Genomics has been awarded a $7.5 million phase I contract by the U.S. Department of Homeland Security Advanced Research Project Agency (HSARPA) to develop a sophisticated biological sensor for...

Artificial cells will pave the way for new treatment modalities.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Artificial cells will pave the way for new treatment modalities. "The artificial cell is a Canadian invention (Chang, Science, 1964). This principle is being actively investigated for use in cell...

Genetically modified Sertoli cells survive allogeneic transplantation.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Genetically modified Sertoli cells survive allogeneic transplantation. "The immunoprotective nature of the testis has led to numerous investigations for its ability to protect cellular grafts....